Record NNP B-NP O
date NN I-NP O
: : O O
2067-03-06 CD O B-DATE
INTERNAL NNP B-NP O
MEDICINE NNP I-NP O
ASSOCIATES NNPS I-NP O
OCHILTREE NN B-NP B-HOSPITAL
GENERAL NNP I-NP I-HOSPITAL
HOSPITAL NNP I-NP I-HOSPITAL
History NN B-NP O
of IN B-PP O
present JJ B-NP O
illness NN I-NP O
This DT B-NP O
is VBZ B-VP O
a DT B-NP O
54 CD I-NP B-AGE
-year-old JJ I-NP O
white JJ I-NP O
male NN I-NP O
here RB B-VP O
complaining VBG I-VP O
persistent JJ B-NP O
cough NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
a DT B-NP O
dry JJ I-NP O
cough NN I-NP O
for IN B-PP O
about IN B-NP O
two CD I-NP O
months NNS I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
put VBN I-VP O
on IN B-PP O
inhalers NNS B-NP O
, , O O
but CC O O
there EX B-NP O
was VBD B-VP O
no DT B-NP O
improvement NN I-NP O
. . O O
The DT O O
cough NN B-NP O
is VBZ B-VP O
worse JJR B-ADJP O
at IN B-PP O
night NN B-NP O
, , O O
but CC O O
also RB B-ADVP O
he PRP B-NP O
has VBZ B-VP O
it PRP B-NP O
during IN B-PP O
the DT B-NP O
day NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
no DT B-NP O
mucus NN I-NP O
production NN I-NP O
, , O O
no DT B-NP O
hemoptysis NN I-NP O
, , O O
no DT B-NP O
shortness NN I-NP O
of IN B-PP O
breath NN B-NP O
, , O O
and CC O O
no DT B-NP O
wheezing JJ I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
a DT B-NP O
nonsmoker NN I-NP O
. . O O
About IN B-PP O
a DT B-NP O
week NN I-NP O
ago RB B-ADVP O
, , O O
he PRP B-NP O
was VBD B-VP O
admitted VBN I-VP O
to TO B-PP O
a DT B-NP O
local JJ I-NP O
emergency NN I-NP O
room NN I-NP O
for IN B-PP O
chest NN B-NP O
pain NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
rushed VBN I-VP O
to TO B-PP O
Ochiltree NNP B-NP B-HOSPITAL
General NNP I-NP I-HOSPITAL
because IN B-PP O
of IN I-PP O
ST-T NNP B-NP O
wave NN I-NP O
abnormalities NNS I-NP O
on IN B-PP O
his PRP$ B-NP O
EKG. NNP I-NP O
In IN B-PP O
retrospect NN B-NP O
, , O O
he PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
these DT B-NP O
changes NNS I-NP O
for IN B-PP O
many JJ B-NP O
years NNS I-NP O
, , O O
and CC O O
anyway RB B-ADVP O
he PRP B-NP O
had VBD B-VP O
a DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
, , O O
which WDT B-NP O
showed VBD B-VP O
mild JJ B-NP O
obstruction NN I-NP O
of IN B-PP O
some DT B-NP O
of IN B-PP O
his PRP$ B-NP O
coronary JJ I-NP O
systems NNS I-NP O
but CC O O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
coronary JJ B-NP O
artery NN I-NP O
syndrome NN I-NP O
. . O O
He PRP B-NP O
did VBD B-VP O
have VB I-VP O
cardiomyopathy NN B-NP O
with IN B-PP O
the DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-PP O
35 CD B-NP O
% NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
sent VBN I-VP O
home NN B-NP O
on IN B-PP O
Toprol NNP B-NP O
XL NNP I-NP O
50 CD I-NP O
mg NN I-NP O
QD NNP I-NP O
, , O O
Lipitor NNP B-NP O
10 CD I-NP O
mg NN I-NP O
QD NNP I-NP O
, , O O
lisinopril NN B-NP O
10 CD I-NP O
mg NN I-NP O
, , O O
aspirin RB B-ADVP O
325 CD B-NP O
mg NN I-NP O
once RB B-SBAR O
a DT B-NP O
day NN I-NP O
, , O O
and CC O O
Avandia NNP B-NP O
2 CD I-NP O
mg NN I-NP O
once RB B-SBAR O
a DT B-NP O
day NN I-NP O
. . O O
Since IN B-PP O
returning VBG B-VP O
home NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
feels VBZ B-VP O
no DT B-NP O
chest NN I-NP O
pain NN I-NP O
or CC I-NP O
shortness NN I-NP O
of IN B-PP O
breath NN B-NP O
. . O O
No DT B-NP O
orthopnea NN I-NP O
or CC O O
PND. NNP B-NP O
He PRP B-NP O
still RB B-ADVP O
has VBZ B-VP O
a DT B-NP O
dry JJ I-NP O
cough NN I-NP O
. . O O
Change NNP B-NP O
in IN B-PP O
therapies NNS B-NP O
and CC I-NP O
Renewals NNS I-NP O
Viagra NNP B-NP O
50mg CD I-NP O
PRN NNP I-NP O
QTY NNP I-NP O
:15 VBD B-VP O
Refills NNP B-NP O
:3 CD I-NP O
Start NNP I-NP O
: : O O
10/05/2063 CD O B-DATE
Avandia NNP B-NP O
2 CD I-NP O
mg NN I-NP O
1 CD I-NP O
tab NN I-NP O
qd NN I-NP O
QTY:30 IN B-PP O
Refills NNP B-NP O
:3 CD I-NP O
Start NNP I-NP O
: : O O
1/31/2065 CD O B-DATE
aspirin NN B-NP O
325 CD I-NP O
mg NN I-NP O
1 CD I-NP O
tab NN I-NP O
qd CC O O
QTY:30 CD B-NP O
Refills NNS I-NP O
:1 IN B-PP O
yr JJ B-NP O
Start NNP I-NP O
: : O O
3/12/2065 CD O B-DATE
lisinopril NN B-NP O
10 CD I-NP O
mg NN I-NP O
QD NNP I-NP O
Start NNP I-NP O
: : O O
8/4/2066 CD O B-DATE
Lipitor NNP B-NP O
10mg CD I-NP O
po NN I-NP O
qd NN I-NP O
Start NNP I-NP O
: : O O
12/17/2066 CD O B-DATE
Proventil JJ B-NP O
two CD I-NP O
puffs NNS I-NP O
inhaled VBD B-VP O
qid VBN I-VP O
QTY NNP B-NP O
:1 CD I-NP O
cannister NN I-NP O
Refills NNS I-NP O
:3 IN B-PP O
Start NNP B-NP O
: : O O
1/28/2067 CD B-NP B-DATE
End NN I-NP O
: : O O
3/06/2067 CD B-NP B-DATE
prn NN I-NP O
- : O O
Inactivated CC O O
Toprol NNP B-NP O
XL NNP I-NP O
50 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd VBD B-VP O
Start NNP B-NP O
: : O O
03/06/2067 CD O B-DATE
Prilosec NNP B-NP O
20mg CD I-NP O
po NN I-NP O
bid NN I-NP O
QTY NNP B-NP O
:60 CD I-NP O
Refills NNP I-NP O
:1 CD I-NP O
Start NNP I-NP O
: : O O
03/06/2067 CD B-NP B-DATE
take VBP B-VP O
before RB B-ADVP O
meals NNS B-NP O
Physical JJ B-NP O
examination NN I-NP O
Blood NN B-NP O
pressure NN I-NP O
110/8 CD I-NP O
0 CD O O
Weight NNP B-NP O
214 CD I-NP O
pounds NNS I-NP O
General NNP B-NP O
appearance NN I-NP O
Well-developed . O O
and CC O O
well-nourished JJ B-NP O
, , O O
no DT B-NP O
acute JJ I-NP O
distress NN I-NP O
Skin NNP B-NP O
Clear NNP I-NP O
Heent NNP B-NP O
Eyes NNP I-NP O
, , O O
nonicteric JJ B-NP O
. . O O
Nose DT O O
clear JJ B-ADJP O
. . O O
Pharynx NNP O O
normal JJ O O
Neck NNP B-NP O
No DT I-NP O
masses NNS I-NP O
. . B-NP O
Neck NN I-NP O
veins VBZ B-VP O
not RB I-VP O
distended VBN I-VP O
Chest NNP B-NP O
Lungs NNP I-NP O
clear JJ O O
Cor NNP B-NP O
Regular NNP I-NP O
rhythm NN I-NP O
. . O O
S1 . O O
and CC O O
S2 JJ B-NP O
normal JJ I-NP O
. . O O
No DT B-NP O
murmur NN I-NP O
, , O O
S3 NNP B-NP O
, , O O
or CC O O
S4 CD O O
Abdomen NNP B-NP O
Soft NNP I-NP O
, , O O
nontender NN B-NP O
, , O O
and CC O O
no DT B-NP O
masses NNS I-NP O
. . O O
No NN B-NP O
liver NN I-NP O
or CC I-NP O
spleen NN I-NP O
palpable NN I-NP O
Extrem NNP B-NP O
No DT B-NP O
edema NN I-NP O
Assessment NNP B-NP O
and CC I-NP O
plan NN I-NP O
Cardiomyopathy NNP B-NP O
. . I-NP O
Continue NNP I-NP O
present JJ I-NP O
medications NNS I-NP O
. . O O
Complete NNP B-NP O
abstention NN I-NP O
from IN B-PP O
alcohol NN B-NP O
advised VBN B-VP O
. . O O
Diabetes NNP B-NP O
. . B-VP O
Check VB I-VP O
hemoglobin NN B-NP O
A1c NN I-NP O
. . O O
Persistent JJ B-NP O
cough NN I-NP O
. . O O
Question NN B-NP O
GERD. NNP I-NP O
Plan NNP I-NP O
: : O O
A DT B-NP O
trial NN I-NP O
of IN B-PP O
Prilosec NNP B-NP O
20 CD I-NP O
mg NN I-NP O
twice RB B-SBAR O
a DT B-NP O
day NN I-NP O
. . O O
Schedule NNP B-NP O
upper JJ I-NP O
GI. NNP I-NP O
Return NN I-NP O
in IN B-PP O
one CD B-NP O
month NN I-NP O
. . O O
If IN B-SBAR O
cough NN B-NP O
persists NNS I-NP O
, , O O
consider VB B-VP O
a DT B-NP O
role NN I-NP O
of IN B-PP O
lisinopril NN B-NP O
. . O O
However RB B-ADVP O
, , O O
he PRP B-NP O
was VBD B-VP O
taking VBG I-VP O
lisinopril JJ B-NP O
long RB B-ADVP O
before IN B-PP O
his PRP$ B-NP O
cough NN I-NP O
started VBD B-VP O
. . O O
Hyperlipidemia NNP B-NP O
. . I-NP O
Continue NNP I-NP O
Lipitor NNP I-NP O
. . O O
Check VB B-VP O
lipid JJ B-NP O
profile NN I-NP O
. . O O
Impotence NN B-NP O
. . O O
Refill NN B-NP O
Viagra NNP I-NP O
. . O O
Note VB B-VP O
transcribed VBN I-VP O
by IN B-PP O
outside JJ B-NP O
service NN I-NP O
Transcription NNP I-NP O
errors NNS I-NP O
may MD B-VP O
be VB I-VP O
present JJ B-ADJP O
. . O O
Signed VBN B-VP O
electronically RB B-ADVP O
by IN B-PP O
Thomson NNP B-NP I-DOCTOR
, , O I-DOCTOR
Steven NNP B-NP I-DOCTOR
on IN B-PP O
Mar NNP B-NP B-DATE
09 CD I-NP I-DATE
, , I-NP I-DATE
2067 CD O I-DATE
